In reply I - Reversal of medical practices

Mayo Clinic Proceedings

Volumn 88, Issue 10, 2013, Pages 1183-1184

  Prasad, Vinay ^a   Cifu, Adam ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DASATINIB; IMATINIB; INTERFERON; NILOTINIB; PROTEIN TYROSINE KINASE INHIBITOR;

CHRONIC MYELOID LEUKEMIA; CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; HUMAN; LETTER; MEDICAL PRACTICE; PERCUTANEOUS CORONARY INTERVENTION; PULMONARY ARTERY CATHETER; STABLE ANGINA PECTORIS;

EID: 84888609667     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.08.011     Document Type: Letter

References (6)

1. Prasad V, Vandross A, Toomey C, et al. A decade of reversal: an analysis of 146 contradicted medical practices. Mayo Clin Proc. 2013;88(8):790-798.
2. Boden WE, O'Rourke RA, Teo KK, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516.
3. Weinstein KJ. A simple health-care fix fizzles out The Wall Street Journal website.http://online.wsj.com/article/ SB10001424052748703652104574652401818092212.html. Published February 11, 2010. Accessed August 11, 2013.
4. Tatsioni A, Bonitsis NG, Ioannidis JP. Persistence of contradicted claims in the literature. JAMA. 2007; 298(21):2517-2526.
5. Hall JB. Use of the pulmonary artery catheter in critically ill patients: was invention the mother of necessity [editorial]? JAMA. 2000;283(19):2577- 2578.
6. Cortes J, Kantarjian H. How I treat newly diagnosed chronic phase CML. Blood. 2012;120(7):1390-1397